Cardiac workload in patients with sleep-disordered breathing early after acute myocardial infarction

Chest

Volumn 143, Issue 5, 2013, Pages 1294-1301

  Hetzenecker, Andrea ^a   Buchner, Stefan ^b   Greimel, Tanja ^b   Satzl, Anna ^b   Luchner, Andreas ^b   Debl, Kurt ^b   Husser, Oliver ^b   Hamer, Okka W ^b   Fellner, Claudia ^b   Riegger, Günter A J ^b   Pfeifer, Michael ^a,b   Arzt, Michael ^b  

^a Donaustauf Hospital   (Germany)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AMLODIPINE; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM ANTAGONIST; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LOOP DIURETIC AGENT; METOPROLOL; RAMIPRIL; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TORASEMIDE;

ACUTE HEART INFARCTION; ADULT; ARTERIAL PRESSURE; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NONHUMAN; OBSERVATIONAL STUDY; OXYGEN SATURATION; PERCUTANEOUS CORONARY INTERVENTION; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REM SLEEP; SLEEP DISORDERED BREATHING; SLEEP TIME; SLOW WAVE SLEEP; SYSTOLIC BLOOD PRESSURE;

EID: 84877624276     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1930     Document Type: Article

References (38)

1. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham study. N Engl J Med. 1971;285(26):1441-1446.
2. Bogaert J, Maes A, Van de Werf F, et al. Functional recovery of subepicardial myocardial tissue in transmural myocardial infarction after successful reperfusion: an important contribution to the improvement of regional and global left ventricular function. Circulation. 1999;99(1):36-43. (Pubitemid 29035955)
3. Granger CB, Goldberg RJ, Dabbous O, et al Global Registry of Acute Coronary Events Investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med. 2003;163(19):2345-2353. (Pubitemid 37310196)
4. Lee KL, Woodlief LH, Topol EJ, et al GUSTO-I Investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. Circulation. 1995;91(6):1659-1668.
5. Steg PG, Kerner A, Van de Werf F, et al Global Registry of Acute Coronary Events (GRACE) Investigators. Impact of in-hospital revascularization on survival in patients with non-ST-elevation acute coronary syndrome and congestive heart failure. Circulation. 2008;118(11):1163-1171.
6. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation. 1990;81(4):1161-1172. (Pubitemid 20119612)
7. Lamas GA, Pfeffer MA, Braunwald E. Patency of the infarct-related coronary artery and ventricular geometry. Am J Cardiol. 1991;68(14):41D-51D.
8. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G; The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 2000;342(3):145-153. (Pubitemid 30051645)
9. Pfeffer MA, Greaves SC, Arnold JM, et al. Early versus delayed angiotensin-converting enzyme inhibition therapy in acute myocardial infarction. The healing and early afterload reducing therapy trial. Circulation. 1997;95(12):2643-2651. (Pubitemid 27255493)
10. Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet. 2001;357(9266):1385-1390. (Pubitemid 32455364)
11. Buchner S, Greimel T, Hetzenecker A, et al. Natural course of sleep-disordered breathing after acute myocardial infarction [published online ahead of print March 22, 2012]. Eur Respir J.
12. Becker HF, Jerrentrup A, Ploch T, et al. Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation. 2003;107(1):68-73. (Pubitemid 36070935)
13. Pepperell JCT, Ramdassingh-Dow S, Crosthwaite N, et al. Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet. 2002;359(9302):204-210. (Pubitemid 34113817)
14. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51(6):1403-1419.
15. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;96(4):1897-1904.
16. Grassi G, Facchini A, Trevano FQ, et al. Obstructive sleep apnea-dependent and -independent adrenergic activation in obesity. Hypertension. 2005;46(2):321-325. (Pubitemid 41099164)
17. Pedrosa RP, Drager LF, Gonzaga CC, et al. Obstructive sleep apnea: the most common secondary cause of hypertension associated with resistant hypertension. Hypertension. 2011;58(5):811-817.
18. Padeletti M, Green P, Mooney AM, Basner RC, Mancini DM. Sleep disordered breathing in patients with acutely decompensated heart failure. Sleep Med. 2009;10(3):353-360.
19. Jelic S, Le Jemtel TH. Sleep-disordered breathing in acute decompensated heart failure. Curr Heart Fail Rep. 2009;6(3):169-175.
20. Van de Werf F, Bax J, Betriu A, et al ESC Committee for Practice Guidelines (CPG). Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29(23):2909-2945.
21. Iber C. The AASM Manual for the Scoring of Sleep and Associated Events. Rules, Terminology and Technical Specifications. Westchester, IL: American Academy of Sleep Medicine; 2007.
22. Baller D, Bretschneider HJ, Hellige G. Validity of myocardial oxygen consumption parameters. Clin Cardiol. 1979;2(5):317-327. (Pubitemid 10181851)
23. Kitamura K, Jorgensen CR, Gobel FL, Taylor HL, Wang Y. Hemodynamic correlates of myocardial oxygen consumption during upright exercise. J Appl Physiol. 1972;32(4):516-522.
24. Uen S, Baulmann J, Düsing R, Glänzer K, Vetter H, Mengden T. ST-segment depression in hypertensive patients is linked to elevations in blood pressure, pulse pressure and double product by 24-h Cardiotens monitoring. J Hypertens. 2003;21(5):977-983. (Pubitemid 36677163)
25. Maldonado G, Greenland S. Simulation study of confounder-selection strategies. Am J Epidemiol. 1993;138(11):923-936. (Pubitemid 24002359)
26. Henskens LH, Kroon AA, van Oostenbrugge RJ, Haest RJ, Lodder J, de Leeuw PW. Different classifications of nocturnal blood pressure dipping affect the prevalence of dippers and nondippers and the relation with target-organ damage. J Hypertens. 2008;26(4):691-698. (Pubitemid 351354916)
27. Davies CW, Crosby JH, Mullins RL, Barbour C, Davies RJ, Stradling JR. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax. 2000;55(9):736-740. (Pubitemid 30660899)
28. Pankow W, Nabe B, Lies A, et al. Influence of sleep apnea on 24-hour blood pressure. Chest. 1997;112(5):1253-1258. (Pubitemid 27497856)
29. Leung RST, Floras JS, Lorenzi-Filho G, Rankin F, Picton P, Bradley TD. Influence of Cheyne-Stokes respiration on cardiovascular oscillations in heart failure. Am J Respir Crit Care Med. 2003;167(11):1534-1539. (Pubitemid 37363364)
30. Sarnoff SJ, Braunwald E, Welch GH Jr, Case RB, Stainsby WN, Macruz R. Hemodynamic determinants of oxygen consumption of the heart with special reference to the tension-time index. Am J Physiol. 1958;192(1):148-156.
31. Hamilton GS, Meredith IT, Walker AM, Solin P. Obstructive sleep apnea leads to transient uncoupling of coronary blood flow and myocardial work in humans. Sleep. 2009;32(2):263-270.
32. Peled N, Abinader EG, Pillar G, Sharif D, Lavie P. Nocturnal ischemic events in patients with obstructive sleep apnea syndrome and ischemic heart disease: effects of continuous positive air pressure treatment. J Am Coll Cardiol. 1999;34(6):1744-1749.
33. Tkacova R, Rankin F, Fitzgerald FS, Floras JS, Bradley TD. Effects of continuous positive airway pressure on obstructive sleep apnea and left ventricular afterload in patients with heart failure. Circulation. 1998;98(21):2269-2275. (Pubitemid 28533845)
34. Kaneko Y, Floras JS, Usui K, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med. 2003;348(13):1233-1241. (Pubitemid 36359299)
35. Swedberg K, Komajda M, Böhm M, et al SHIFT Investigators. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376(9744):875-885.
36. Portaluppi F, Provini F, Cortelli P, et al. Undiagnosed sleep-disordered breathing among male nondippers with essential hypertension. J Hypertens. 1997;15(11):1227-1233. (Pubitemid 27453174)
37. Freemantle N, Cleland J, Young P, Mason J, Harrison J. beta Blockade after myocardial infarction: systematic review and meta regression analysis. BMJ. 1999;318(7200):1730-1737. (Pubitemid 29290470)
38. Nakashima H, Katayama T, Takagi C, et al. Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarction. Eur Heart J. 2006;27(19):2317-2322. (Pubitemid 44453575)